🚀 Business & Startups🌐 Global
J&J Agrees To Pay ₹52,700 Crore To Settle Baby Powder Cancer Lawsuits
mint - companies·Wednesday, 29 July 2026
Johnson & Johnson has agreed to pay nearly ₹52,700 crore to settle lawsuits that linked its talc-based baby powder to ovarian cancer. J&J has maintained that its products do not cause cancer and that it marketed baby powder appropriately for over a century. The settlement resolves a long-running legal battle.
Why It Matters
J&J's baby powder has been used by families for generations worldwide, including in India. This settlement is one of the largest product-liability payouts in corporate history.
🔒 Potential Impact + source link
Subscribe to unlock the impact analysis and original source for every story.